CTI BioPharma Corp. ( NASDAQ:CTIC – Get Rating ) saw a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 12,170,000 shares, a drop of 24.2% from the April 15th total of 16,050,000 shares. Based on an average daily volume of 3,010,000 shares, the days-to-cover ratio is presently 4.0 days. Wall Street Analysts Forecast Growth A number of equities research analysts have weighed in on the company. StockNews.com raised CTI BioPharma from a 'sell' rating to a 'hold' rating in a report on Tuesday, March 14th.

https://www.dailypolitical.com/2023/05/14/short-interest-in-cti-biopharma-corp-nasdaqctic-drops-by-24-2.html

#dailypolitical